Stoke Therapeutics, Inc.

The current price of STOK is 12.05 USD — it has increased by 3.43% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Stoke Therapeutics, Inc. stocks are traded under the ticker STOK.

Stoke Therapeutics, Inc. is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.

STOK stock is 6.09% volatile and has beta coefficient of 2.23. Check out the list of the most volatile stocks — is Stoke Therapeutics, Inc. there?

One year price forecast for Stoke Therapeutics, Inc. has a max estimate of 35.00 USD and a min estimate of 14.00 USD.

STOK earnings for the last quarter are −0.55 USD per share, whereas the estimation was −0.63 USD resulting in a 13.04% surprise. The estimated earnings for the next quarter are −0.61 USD per share. See more details about Stoke Therapeutics, Inc. earnings.

Stoke Therapeutics, Inc. revenue for the last quarter amounts to ‪3.31 M‬ USD despite the estimated figure of ‪3.64 M‬ USD. In the next quarter revenue is expected to reach ‪3.66 M‬ USD.

Yes, you can track Stoke Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.

STOK net income for the last quarter is ‪−26.96 M‬ USD, while the quarter before that showed ‪−24.54 M‬ USD of net income which accounts for −9.84% change. Track more Stoke Therapeutics, Inc. financial stats to get the full picture.

Today Stoke Therapeutics, Inc. has the market capitalization of ‪604.16 M‬, it has decreased by 0.61% over the last week.

No, STOK doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, STOK shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Stoke Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.

STOK reached its all-time high on Jan 20, 2021 with the price of 71.58 USD, and its all-time low was 3.35 USD and was reached on Oct 27, 2023.
See other stocks reaching their highest and lowest prices.

As of Apr 20, 2024, the company has 110.00 employees. See our rating of the largest employees — is Stoke Therapeutics, Inc. on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Stoke Therapeutics, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Stoke Therapeutics, Inc. stock shows the buy signal. See more of Stoke Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

We've gathered analysts' opinions on Stoke Therapeutics, Inc. future price: according to them, STOK price has a max estimate of 35.00 USD and a min estimate of 14.00 USD. Read a more detailed Stoke Therapeutics, Inc. forecast: see what analysts think of Stoke Therapeutics, Inc. and suggest that you do with its stocks.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Stoke Therapeutics, Inc. EBITDA is ‪−110.04 M‬ USD, and current EBITDA margin is ‪−1.25 K‬%. See more stats in Stoke Therapeutics, Inc. financial statements.